Clinical Trial Update: 18F-Fluciclovine PET-MRI in High-grade Glioma [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluating 18F-Fluciclovine PET-MRI for imaging high-grade glioma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Glioma
• Glioma
• High-grade Glioma
• Intracranial Glioma
• Malignant Glioma

Drugs mentioned

• Axumin (fluciclovine F-18)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Glioma, High Grade Glioma | EARLY_Phase 1 | Status: RECRUITING